Development of a highly-efficient erythrocyte-drug covalent conjugation platform and its use in treating thrombotic disorders

Cell Res. 2023 Nov;33(11):887-890. doi: 10.1038/s41422-023-00868-2. Epub 2023 Sep 4.

Yanjie Huang^#^{1

2

3

4}, Xiaoqian Nie^#^{1

2

3

4}, Xuewen Liu^#^{1

2

3

4}, Yuehua Liu^{2

3

4

5}, Huifei Yu⁶, Xiaofei Gao^{7

8

9}

¹ School of Basic Medical Sciences, Fudan University, Shanghai, China.
² Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.
³ Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.
⁴ Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang, China.
⁵ College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
⁶ Westlake Therapeutics, Inc., Hangzhou, Zhejiang, China.
⁷ Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China. gaoxiaofei@westlake.edu.cn.
⁸ Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China. gaoxiaofei@westlake.edu.cn.
⁹ Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang, China. gaoxiaofei@westlake.edu.cn.

^# Contributed equally.

No abstract available

Publication types